AP879A - Method and compositions for the synthesis of dioxolane nucleosides with b-configuration. - Google Patents

Method and compositions for the synthesis of dioxolane nucleosides with b-configuration. Download PDF

Info

Publication number
AP879A
AP879A APAP/P/1998/001252A AP9801252A AP879A AP 879 A AP879 A AP 879A AP 9801252 A AP9801252 A AP 9801252A AP 879 A AP879 A AP 879A
Authority
AP
ARIPO
Prior art keywords
group
hydrogen
formula
process according
alkyl
Prior art date
Application number
APAP/P/1998/001252A
Other languages
English (en)
Other versions
AP9801252A0 (en
Inventor
Tarek Mansour
Alex Cimpola
Krzysztof Bednarski
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Publication of AP9801252A0 publication Critical patent/AP9801252A0/xx
Application granted granted Critical
Publication of AP879A publication Critical patent/AP879A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
APAP/P/1998/001252A 1995-12-14 1996-12-13 Method and compositions for the synthesis of dioxolane nucleosides with b-configuration. AP879A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9525606.1A GB9525606D0 (en) 1995-12-14 1995-12-14 Method and compositions for the synthesis of dioxolane nucleosides with › - configuration
PCT/CA1996/000845 WO1997021706A1 (en) 1995-12-14 1996-12-13 METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION

Publications (2)

Publication Number Publication Date
AP9801252A0 AP9801252A0 (en) 1998-06-30
AP879A true AP879A (en) 2000-10-02

Family

ID=10785435

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001252A AP879A (en) 1995-12-14 1996-12-13 Method and compositions for the synthesis of dioxolane nucleosides with b-configuration.

Country Status (28)

Country Link
US (4) US5922867A (cs)
EP (1) EP0970074B1 (cs)
JP (1) JP3229990B2 (cs)
KR (1) KR100406159B1 (cs)
CN (1) CN1080263C (cs)
AP (1) AP879A (cs)
AT (1) ATE214699T1 (cs)
AU (1) AU706328B2 (cs)
BR (1) BR9612351A (cs)
CA (1) CA2237730C (cs)
DE (1) DE69620042T2 (cs)
DK (1) DK0970074T3 (cs)
EA (1) EA000844B1 (cs)
ES (1) ES2172697T3 (cs)
GB (1) GB9525606D0 (cs)
HK (1) HK1017886A1 (cs)
HU (1) HU224076B1 (cs)
IL (3) IL144155A (cs)
IN (1) IN187349B (cs)
MX (1) MX9804701A (cs)
NO (1) NO309901B1 (cs)
NZ (1) NZ323855A (cs)
OA (1) OA11094A (cs)
PL (1) PL188447B1 (cs)
PT (1) PT970074E (cs)
TW (1) TW341574B (cs)
WO (1) WO1997021706A1 (cs)
ZA (1) ZA9610544B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044913A2 (en) 1997-04-07 1998-10-15 Triangle Pharmaceuticals, Inc. Compositions containing mkc-442 in combination with other antiviral agents
EP1104415B1 (en) 1998-08-12 2004-11-10 Gilead Sciences, Inc. Method of manufacture of 1,3-oxathiolane nucleosides
US6979561B1 (en) * 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
MXPA01006425A (es) * 1998-12-23 2002-06-04 Iaf Biochem Int Analogos de nucleosido antivirales.
AU2653200A (en) * 1999-02-11 2000-08-29 Biochem Pharma Inc. Stereoselective synthesis of nucleoside analogues
US6583149B1 (en) * 1999-09-24 2003-06-24 Biochem Pharma Inc. Method for the treatment or prevention of viral infection using nucleoside analogues
AU1262001A (en) * 1999-11-04 2001-05-14 Biochem Pharma Inc. Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
US7038039B2 (en) * 2000-02-10 2006-05-02 Mitsui Chemicals, Inc. Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside
JP2003522769A (ja) * 2000-02-11 2003-07-29 シェア バイオケム インコーポレーテッド ヌクレオシド類似体の立体選択的合成
WO2002051852A1 (fr) * 2000-12-27 2002-07-04 Mitsui Chemicals, Inc. Procede de production d'un derive de saccharide non naturel
ATE383355T1 (de) 2001-03-01 2008-01-15 Abbott Lab Polymorph und andere kristallinische formen von zusammen-ftc
AU2002329970A1 (en) * 2001-09-04 2003-03-18 Isis Pharmaceuticals, Inc. Pyrrolo(2,3-d)pyrimidines for inhibiting rna-dependent rna viral polymerase
EP1441733A1 (en) * 2001-11-02 2004-08-04 Shire Biochem Inc. Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs
CA2470255C (en) 2001-12-14 2012-01-17 Kyoichi A. Watanabe N4-acylcytosine nucleosides for treatment of viral infections
EP1467990B1 (en) * 2002-01-25 2012-03-07 Shire BioChem Inc. Process for producing dioxolane nucleoside analogue precursors
ATE496054T1 (de) 2002-08-06 2011-02-15 Pharmasset Inc Verfahren zur herstellung von 1,3-dioxolan- nucleosiden
KR101113341B1 (ko) 2002-10-15 2012-09-27 엑손모빌 케미칼 패턴츠 인코포레이티드 올레핀 중합용 다중 촉매 시스템 및 이로부터 제조된중합체
DE10335061B4 (de) 2003-07-31 2005-11-17 Wacker-Chemie Gmbh Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten
WO2005074654A2 (en) * 2004-02-03 2005-08-18 Emory University Methods to manufacture 1,3-dioxolane nucleosides
US7749531B2 (en) * 2005-06-08 2010-07-06 Indicator Systems International Apparatus and method for detecting bacterial growth beneath a wound dressing
BRPI0813036A2 (pt) * 2007-07-30 2017-10-24 Rfs Pharma Llc processo estereosseletivo para preparar derivados do nucleosídeo dioxolana de purina.
CN101862676B (zh) * 2009-04-17 2012-01-25 中国石油化工股份有限公司 大孔径sba-15介孔材料-三氟甲磺酸铜复合催化剂、制备方法及应用
CN103288806A (zh) * 2013-07-02 2013-09-11 山东大学 一种曲沙他滨的合成方法
WO2018022263A1 (en) 2016-07-29 2018-02-01 Exxonmobil Chemical Patents Inc. Polymerization processes using high molecular weight polyhydric quenching agents
JP7337539B2 (ja) * 2018-06-21 2023-09-04 メディヴィル・アクチエボラーグ 白血病療法のための塩基修飾シチジンヌクレオチド
WO2019245444A1 (en) 2018-06-21 2019-12-26 Medivir Ab Base-modified cytidine nucleotides for leukemia therapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014729A1 (en) * 1991-02-22 1992-09-03 Emory University Antiviral 1,3-dioxolane nucleosides and synthesis thereof
EP0577304A1 (en) * 1992-06-22 1994-01-05 Eli Lilly And Company Stereoselective anion glycosylation process

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014729A1 (en) * 1991-02-22 1992-09-03 Emory University Antiviral 1,3-dioxolane nucleosides and synthesis thereof
EP0577304A1 (en) * 1992-06-22 1994-01-05 Eli Lilly And Company Stereoselective anion glycosylation process

Also Published As

Publication number Publication date
US20020058670A1 (en) 2002-05-16
DE69620042T2 (de) 2002-10-17
NO982716L (no) 1998-06-12
CA2237730C (en) 2001-12-04
IL124663A (en) 2001-10-31
DK0970074T3 (da) 2002-07-15
DE69620042D1 (de) 2002-04-25
IL144155A (en) 2003-07-06
TW341574B (en) 1998-10-01
HU224076B1 (hu) 2005-05-30
IN187349B (cs) 2002-03-30
PT970074E (pt) 2002-09-30
US20030060476A1 (en) 2003-03-27
MX9804701A (es) 1998-10-31
GB9525606D0 (en) 1996-02-14
AP9801252A0 (en) 1998-06-30
AU706328B2 (en) 1999-06-17
WO1997021706A1 (en) 1997-06-19
KR100406159B1 (ko) 2004-11-16
HK1017886A1 (en) 1999-12-03
EA199800555A1 (ru) 1999-02-25
IL144155A0 (en) 2002-05-23
CA2237730A1 (en) 1997-06-19
CN1080263C (zh) 2002-03-06
NO982716D0 (no) 1998-06-12
NZ323855A (en) 1999-11-29
PL188447B1 (pl) 2005-02-28
BR9612351A (pt) 1999-07-13
JP3229990B2 (ja) 2001-11-19
EA000844B1 (ru) 2000-06-26
ATE214699T1 (de) 2002-04-15
ZA9610544B (en) 1997-07-29
ES2172697T3 (es) 2002-10-01
HUP9901050A3 (en) 2001-05-28
AU1089397A (en) 1997-07-03
JP2000501714A (ja) 2000-02-15
OA11094A (en) 2003-03-13
CN1208414A (zh) 1999-02-17
NO309901B1 (no) 2001-04-17
US6069250A (en) 2000-05-30
IL124663A0 (en) 1998-12-06
PL327443A1 (en) 1998-12-07
US5922867A (en) 1999-07-13
EP0970074A1 (en) 2000-01-12
HUP9901050A2 (hu) 2001-04-28
EP0970074B1 (en) 2002-03-20
KR19990072141A (ko) 1999-09-27

Similar Documents

Publication Publication Date Title
AP879A (en) Method and compositions for the synthesis of dioxolane nucleosides with b-configuration.
EP0515156B1 (en) Processes for the diastereo-selective synthesis of nucleosides
KR0137023B1 (ko) 2-치환-4-치환-1,3-디옥솔란, 이의 합성 및 이의 용도
RU2139870C1 (ru) Способ получения цис-нуклеозидных аналогов, их солей и сложных эфиров
CN102924454B (zh) 恩替卡韦的合成方法
KR20070085075A (ko) 1,3-디옥솔란 뉴클레오시드 제조방법
AU2003294212B2 (en) Processes for preparing 1,3-dioxolane nucleosides
HU223100B1 (hu) Eljárás nukleozidanalógok előállítására és a köztitermékek
WO2003040139A1 (en) Diastereoselective process for the preparation of the antiviral agent4-amino-1-(2r-hydroxymethyl-[1,3]oxathiolan-5s-yl)-1h-pyrimidin-2-one